Multiple sclerosis (MS) is a chronic autoimmune and neurodegenerative disease of the central nervous system (CNS), affecting ...

A Canadian-led international research team, spearheaded by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) has received nearly $800,000 US ($1,137,868 CAD) in new funding to advance ...

Dr Jiwon Oh looks forward to hearing updates on major clinical trials and long-term studies of new and emerging MS treatments at ECTRIMS 2025.

NEW YORK, Sept. 18, 2025 /PRNewswire/ -- The McDonald Diagnostic Criteria for MS - a set of guidelines to help healthcare ...

Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi is conducting a Phase 3 clinical study titled ‘A Randomized, ...

An international research team has secured nearly $800,000 to advance a potential regenerative therapy for MS toward clinical ...

BRIUMVI is indicated in the U.S. for the treatment of adults with RMS, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease and in the EU and ...

In a landmark regulatory achievement that reflects the UAE’s leadership in accelerating access to innovative therapies, the Emirates Drug Establishment has announced the approval of “Tolebrutinib” as ...

A Canadian-led international research team, spearheaded by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) ...

Managing MS treatment plateaus requires honest communication with your doctor and making lifestyle adjustments.

The first signs of multiple sclerosis (MS) may appear much earlier than most doctors once believed. A new study suggests that ...

At the time, she wasn't sure what specialty she wanted to pursue, but her own medical experience guided her. "I had a hard time finding a neurologist," she said. "I couldn't find an MS specialist who ...